Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Oncopeptides AB
F:OND
Oncopeptides AB
F:OND
Price:
0.164
EUR
4.99%
Market Cap:
€34.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Wall St Price Targets
OND Price Forecast
Based on 6 analysts
Based on 6 analysts
+288% Upside
from
€0.164
today
Oncopeptides AB (OND)’s 12-month stock price forecast through November 2027 has a consensus target of €0.637, implying 288% upside. The forecast is based on price targets from 6 Wall Street analysts.
OND Analyst Rating
No ratings yet
No ratings yet
Oncopeptides AB Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is OND's stock price target?
Price Target
0.637
EUR
0.637
EUR
According to Wall Street analysts, the average 1-year price target for OND is 0.637 EUR with a low forecast of 0.504 EUR and a high forecast of 1.049 EUR.
What is the Revenue forecast for Oncopeptides AB?
Projected CAGR
73%
73%
The compound annual growth rate for Revenue over the next 3 years is 73%.
What is the Gross Profit forecast for Oncopeptides AB?
Projected CAGR
62%
62%
The compound annual growth rate for Gross Profit over the next 3 years is 62%.
